Amgen's autoimmune drug succeeds in late-stage trial
- Posted on September 22, 2026
- By Bing News
- 0 Views
- 1 min read
In brief
Generating AI summary…
Amgen's autoimmune drug succeeds in late-stage trial
(Corrects last bullet point to say a separate late-stage trial of the drug is expected to be completed in the fourth quarter) Sept 22 (Reuters) - Amgen said on Tuesday its experimental drug to treat an autoimmune disease that attacks the body's moisture-producing glands met the main goal of reducing disease activity in a late-stage trial. Here are some details: • The drug dazodalibep showed
